Precision Medicine Approaches to Renal Osteodystrophy

RecruitingOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

December 21, 2022

Primary Completion Date

August 17, 2026

Study Completion Date

June 30, 2027

Conditions
Renal OsteodystrophyChronic Kidney DiseasesCKD-MBDBone Turnover Rate DisorderSecondary Hyperparathyroidism
Interventions
PROCEDURE

miRNAseq analysis

Identify miRNA in serum and prepare a miRNA sequencing library for novel analysis.

DRUG

Standard treatment for bone disorder

Participants will be prescribed a clinically indicated bone-targeted treatment for osteoporosis or bone disorder related to CKD. (non-experimental)

Trial Locations (1)

63110

RECRUITING

Washington University in St. Louis (WashU), St Louis

All Listed Sponsors
collaborator

Indiana University School of Medicine

OTHER

collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Thomas Nickolas

OTHER